Skip to content
Portage Biotech
Portage BiotechPortage Biotech
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact

Daily Archives: March 2, 2021

Condensed Consolidated Interim Financial Statements For the Three and Six Months Ended September 30, 2020

Financial and Regulatory ReportsBy Portage Biotech, IncMarch 2, 2021
...

MANAGEMENT’S DISCUSSION AND ANALYSIS Prepared as of November 30, 2020

Financial and Regulatory ReportsBy Portage Biotech, IncMarch 2, 2021
...

PORTAGE ANNOUNCES FILING OF THIRD QUARTER FINANCIAL STATEMENTS

Press ReleaseBy Portage Biotech, IncMarch 2, 2021
...
Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top